Literature DB >> 8219656

Visceral leishmaniasis (kala-azar) after a visit to the Mediterranean region.

J Rudi1, P Racz, M Hörner, B Kommerell.   

Abstract

The case of a 17-year-old patient is presented who became ill 10 months after a holiday visit to Malta. Symptoms included fever peaking daily at 40 degrees C, pancytopenia, and splenomegaly. There was no evidence of bacterial or virological involvement, and probatory treatment with antibiotics followed by corticosteroids was without success. Examination of bone marrow led to the diagnosis of visceral leishmaniasis (kala-azar). A therapy with pentavalent antimony brought rapid improvement in clinical symptoms and led to complete recovery. A short review is presented of the epidemiology, diagnosis, and therapy of visceral leishmaniasis. The aim of this presentation is to remind the attendant physician of the clinical symptoms involved with the possible case of visceral leishmaniasis.

Entities:  

Mesh:

Year:  1993        PMID: 8219656     DOI: 10.1007/bf00184486

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  19 in total

1.  Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar.

Authors:  J P Wali; P Aggarwal; U Gupta; S Saluja; S Singh
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

2.  Serodiagnosis of Indian kala-azar: evaluation of IFA, ELISA and CIEP tests.

Authors:  V Mittal; R Bhatia; S Sehgal
Journal:  J Commun Dis       Date:  1991-06

3.  Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

Authors:  R Badaro; E Falcoff; F S Badaro; E M Carvalho; D Pedral-Sampaio; A Barral; J S Carvalho; M Barral-Netto; M Brandely; L Silva
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

4.  The leishmaniases. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1984

5.  Involvement of membrane-associated TNF in the killing of Leishmania donovani parasites by macrophages.

Authors:  M L Lohmann-Matthes; B Lüttig; S Hockertz
Journal:  Behring Inst Mitt       Date:  1991-02

6.  New perspectives on a subclinical form of visceral leishmaniasis.

Authors:  R Badaro; T C Jones; E M Carvalho; D Sampaio; S G Reed; A Barral; R Teixeira; W D Johnson
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

7.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan.

Authors:  E E Zijlstra; M S Ali; A M el-Hassan; I A el-Toum; M Satti; H W Ghalib; P A Kager
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jul-Aug       Impact factor: 2.184

9.  Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.

Authors:  E E Zijlstra; M S Ali; A M el-Hassan; I A el-Toum; M Satti; H W Ghalib
Journal:  J Trop Pediatr       Date:  1992-02       Impact factor: 1.165

10.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

Authors:  E M Carvalho; O Bacellar; A Barral; R Badaro; W D Johnson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more
  1 in total

1.  Unusual duodenal presentation of leishmaniasis.

Authors:  M L Alvarez-Nebreda; E Alvarez-Fernández; S Rada; F Brañas; E Marañón; M T Vidán; J A Serra-Rexach
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.